The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer von Ai, Lingbao, Kim, Wan-Ju, Demircan, Berna, Dyer, Lisa M., Bray, Kevin J., Skehan, Ryan R., Massoll, Nicole A., Brown, Kevin D.

Volltext

Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression... von Ai, Lingbao, Skehan, Ryan R., Saydi, John, Lin, Tong, Brown, Kevin D.

Volltext

A systematic review and meta‐analysis of the utility of lymphoscintigraphy in the management of clinically node‐negative breast cancer von Boland, Michael R., Heneghan, Helen M., Ryan, Éanna J., Ain, Qurat, Skehan, Stephen J., McCartan, Damian, Evoy, Denis, Geraghty, James, McDermott, Enda W., Prichard, Ruth S.

Volltext

Method and system for dynamic assignment of entitlements von NIKOLS NICK, SKEHAN JOE, COX RYAN L, CARTER STEPHEN R, STREET WILLIAM, WOOTTON JAY, MORGAN CHARLES, ELSBERRY JASON, FOSTER DENNIS

Volltext bestellen

Method and system for dynamic assignment of entitlements von Wootton, Jay, Foster, Dennis, Skehan, Joe, Morgan, Charles, Elsberry, Jason, Cox, Ryan L, Street, William, Carter, Stephen R, Nikols, Nick

Volltext bestellen